Frankincense (Supplement) for Anti-Inflammatory

Research suggests that frankincense, particularly in the form of Boswellia serrata extracts and their active compounds such as boswellic acids and incensole acetate, has meaningful anti-inflammatory properties supported by a range of study types including mechanistic laboratory research, animal studies, open-label observational trials, small randomized controlled trials, and systematic reviews. Studies indicate that these compounds appear to work through multiple biological pathways, notably by inhibiting NF-κB signaling and suppressing pro-inflammatory markers such as interleukin-6, interleukin-1α, and prostaglandin E, with clinical investigations showing potential benefits across conditions including osteoarthritis, tendinopathy, kidney disease, exercise-induced inflammation, dysmenorrhea, and radiation-related brain swelling. The overall direction of the evidence is supportive, and frankincense is generally reported as well-tolerated with mostly mild gastrointestinal side effects, though many of the clinical studies are small, lack control groups or placebo comparisons, and frequently combine Boswellia with other anti-inflammatory compounds such as curcumin, making it difficult to isolate the specific contribution of frankincense alone. Reviewers and study authors consistently call for larger, well-designed randomized controlled trials before firm conclusions can be drawn about its effectiveness for any specific condition.